Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Editas Medicine (EDIT) Return on Equity (2016 - 2025)

Editas Medicine (EDIT) has disclosed Return on Equity for 10 consecutive years, with 12.11% as the latest value for Q3 2025.

  • Quarterly Return on Equity fell 1108.0% to 12.11% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 12.11% through Sep 2025, down 1108.0% year-over-year, with the annual reading at 0.98% for FY2024, 55.0% down from the prior year.
  • Return on Equity for Q3 2025 was 12.11% at Editas Medicine, down from 5.75% in the prior quarter.
  • The five-year high for Return on Equity was 0.2% in Q4 2021, with the low at 12.11% in Q3 2025.
  • Average Return on Equity over 5 years is 1.51%, with a median of 0.52% recorded in 2024.
  • The sharpest move saw Return on Equity soared 32bps in 2021, then tumbled -1108bps in 2025.
  • Over 5 years, Return on Equity stood at 0.2% in 2021, then plummeted by -189bps to 0.57% in 2022, then rose by 25bps to 0.43% in 2023, then tumbled by -258bps to 1.53% in 2024, then crashed by -691bps to 12.11% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 12.11%, 5.75%, and 2.55% for Q3 2025, Q2 2025, and Q1 2025 respectively.